CN Stock MarketDetailed Quotes

300267 Hunan Er-kang Pharmaceutical

Watchlist

2.24
+0.01+0.45%

Market Closed Sep 3 15:00 CST

4.62BMarket Cap-19145P/E (TTM)

Hunan Er-kang Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

Assets

Current assets

Money funds

17.24%638.9M

-0.88%535.04M

-2.66%744.35M

39.04%501.64M

-32.27%544.93M

-0.02%539.8M

0.41%764.67M

-12.35%360.8M

35.97%804.62M

-47.89%539.93M

Transactional financial assets

927.01%100M

-85.36%143.2K

-99.90%118.6K

----

41.04%9.74M

--978.23K

--114.12M

1,282.17%17.97M

--6.9M

----

Notes receivable and accounts receivable

-8.35%132.01M

-13.39%143.89M

-7.74%146.99M

-42.65%119.31M

-26.64%144.03M

-10.09%166.14M

-15.81%159.33M

-56.52%208.04M

-46.70%196.34M

-54.64%184.79M

-Notes receivable

86.80%24.57M

11.71%35.1M

47.61%37.84M

-96.17%2.12M

-28.96%13.15M

--31.42M

831.26%25.63M

-63.58%55.48M

-82.78%18.52M

----

-Accounts receivable

-17.91%107.44M

-19.24%108.8M

-18.35%109.15M

-23.19%117.18M

-26.40%130.87M

-27.09%134.72M

-28.31%133.69M

-53.23%152.56M

-31.83%177.82M

-38.68%184.79M

Other receivables (including interest and dividends)

0.26%10.89M

135.81%19.26M

-34.66%18.17M

32.31%9.19M

10.93%10.86M

-16.58%8.17M

105.00%27.81M

69.24%6.95M

34.35%9.79M

64.65%9.79M

-Other receivable

0.26%10.89M

----

-34.66%18.17M

----

10.93%10.86M

----

105.00%27.81M

----

34.35%9.79M

----

Advance payment

-83.03%9.17M

-32.29%75.19M

-90.41%8.09M

102.69%151.05M

-37.17%54.02M

34.97%111.05M

-11.17%84.33M

-28.54%74.52M

7.39%85.97M

-41.61%82.28M

Inventories

-16.66%691.49M

-17.82%701.29M

-15.80%691.6M

-19.40%731.12M

0.32%829.67M

11.08%853.42M

14.91%821.34M

14.47%907.06M

-3.75%827M

-2.17%768.32M

Receivable financing

17.45%40.52M

144.02%34.21M

-31.77%30.81M

-55.72%31.66M

-15.87%34.5M

-86.08%14.02M

-46.95%45.15M

--71.5M

--41.01M

--100.74M

Other current assets

-47.02%69.29M

27.61%216.4M

22.07%90.88M

-68.02%150.98M

93.99%130.77M

-45.82%169.58M

-14.59%74.45M

-11.08%472.06M

-87.66%67.41M

-38.35%312.97M

Total current assets

-3.77%1.69B

-7.39%1.73B

-17.22%1.73B

-20.01%1.69B

-13.76%1.76B

-6.79%1.86B

7.44%2.09B

-8.79%2.12B

-16.88%2.04B

-30.68%2B

Non Current assets

Other equity investment

0.00%50M

--50M

Investment real estate

-3.87%79.69M

-4.65%80.49M

-4.66%81.29M

-4.67%82.09M

-4.68%82.89M

-3.86%84.42M

-3.83%85.26M

-3.79%86.11M

-3.75%86.96M

-3.72%87.81M

Long-term equity investment

-4.52%119.66M

-4.53%119.9M

-13.48%120.23M

-10.94%124.74M

-12.66%125.32M

-13.17%125.59M

-4.92%138.97M

-9.34%140.05M

-8.00%143.48M

-7.42%144.65M

Fixed assets

-2.78%2.55B

----

-3.87%2.58B

----

27.01%2.63B

----

35.19%2.68B

----

-19.69%2.07B

----

Constru in process

110.74%237.9M

----

276.78%199.38M

----

-76.04%112.89M

----

-89.32%52.92M

----

-5.90%471.16M

----

Construction materials

-86.37%8.01M

----

--21.51M

----

1,847.16%58.8M

----

52.15%3.02M

----

Intangible assets

-6.29%366.61M

-7.15%372.25M

-6.92%378.03M

-6.69%384.88M

-6.59%391.2M

-5.70%400.93M

-5.87%406.14M

-21.16%412.47M

-18.61%418.81M

-19.42%425.14M

Goodwill

-79.98%2M

0.00%10.01M

-54.15%10.01M

Long deferred expense

-38.47%10.96M

-26.06%13.62M

-38.05%12.08M

-12.78%16.72M

-2.42%17.81M

20.70%18.42M

18.06%19.5M

15.85%19.17M

30.18%18.25M

21.02%15.26M

Deferred tax assets

-8.05%151.73M

-10.20%152.05M

-9.93%152.14M

50.98%161.87M

50.91%165.01M

45.82%169.33M

42.74%168.92M

92.79%107.22M

92.44%109.35M

121.80%116.12M

Usufruct assets

-4.65%117.03M

-1.24%117.66M

-2.72%118.61M

-3.78%120.71M

4.83%122.73M

5.90%119.13M

6.48%121.92M

1,562.71%125.45M

2,700.43%117.08M

--112.5M

Other non current assets

-37.83%40.06M

-51.83%31.04M

19.17%34.96M

79.18%46M

206.16%64.43M

291.80%64.45M

46.01%29.33M

-52.13%25.67M

-66.86%21.04M

-78.35%16.45M

Total non current assets

-2.36%3.74B

-0.02%3.74B

-0.44%3.75B

6.97%3.83B

8.82%3.83B

7.91%3.74B

8.01%3.76B

-12.17%3.58B

-13.13%3.52B

-12.12%3.46B

Total assets

-2.81%5.43B

-2.47%5.46B

-6.43%5.48B

-3.06%5.52B

0.53%5.58B

2.53%5.6B

7.80%5.86B

-10.94%5.7B

-14.54%5.56B

-19.96%5.46B

Liabilities

Current liabilities

Short term loan

128.33%340.21M

76.40%351.03M

-13.80%341.89M

-49.97%149M

-48.07%149M

-27.04%199M

61.24%396.64M

21.05%297.79M

-27.55%286.92M

-58.86%272.75M

Transactional financial liabilities

----

--538.4K

----

Notes payable and accounts payable

-11.60%146.14M

-7.25%157.4M

-38.45%122.3M

-10.66%139.03M

46.10%165.32M

38.37%169.7M

44.12%198.7M

33.60%155.61M

-18.08%113.16M

-6.41%122.64M

-Notes payable

----

--35M

----

-Accounts payable

-11.60%146.14M

-7.25%157.4M

-38.45%122.3M

15.27%139.03M

46.10%165.32M

38.37%169.7M

44.12%198.7M

3.55%120.61M

-18.08%113.16M

-6.41%122.64M

Contract liabilities

18.36%38.95M

6.39%36.72M

-8.36%47.01M

-9.18%36.93M

-18.38%32.91M

-32.44%34.51M

37.37%51.31M

-19.23%40.66M

-11.78%40.33M

19.55%51.08M

Salaries payable

-5.62%9.94M

-8.80%10.56M

11.45%23.86M

-25.50%10.34M

-22.54%10.53M

-16.39%11.58M

-30.06%21.41M

-2.66%13.88M

-7.02%13.59M

-1.36%13.85M

Taxs payable

-57.69%8.03M

-39.36%8.06M

151.93%9.3M

-29.23%14.45M

23.81%18.97M

104.70%13.3M

-23.14%3.69M

45.28%20.42M

21.37%15.32M

-11.72%6.5M

Other payable (including interest and dividends)

-18.61%26.79M

-21.94%29.5M

-26.53%31.85M

-28.98%31.9M

-29.25%32.92M

-11.99%37.79M

27.63%43.35M

59.79%44.92M

45.11%46.53M

59.09%42.93M

-Interest payable

----

--1.79M

--845.64K

----

-Other payable

-18.61%26.79M

----

-26.53%31.85M

----

-27.94%32.92M

----

27.63%43.35M

----

42.47%45.69M

----

Non current liabilities due within one year

-16.62%1.87M

-36.84%2.18M

-47.51%2.16M

-17.45%2.08M

-21.56%2.25M

21.66%3.45M

5.76%4.11M

32.35%2.52M

50.18%2.86M

--2.84M

Other current liabilities

232.46%13.9M

453.90%24.78M

291.69%24.39M

-12.22%4.64M

-18.97%4.18M

-25.84%4.47M

40.00%6.23M

12.65%5.28M

7.81%5.16M

14.06%6.03M

Total current liabilities

40.80%585.83M

30.90%620.23M

-16.84%603.3M

-33.16%388.38M

-20.57%416.08M

-8.64%473.8M

45.40%725.43M

22.12%581.09M

-18.89%523.87M

-41.76%518.62M

Current liabilities

Deferred tax liabilities

-11.50%46.57M

-14.17%46.49M

-13.50%46.2M

74.80%49.5M

88.76%52.62M

97.03%54.16M

82.36%53.41M

1.44%28.32M

0.77%27.88M

-0.34%27.49M

Long term deferred income

-12.82%17.41M

-13.50%18.65M

-20.57%18.39M

-21.85%18.57M

-21.05%19.97M

-18.25%21.56M

-17.06%23.15M

-19.27%23.76M

-18.61%25.29M

-18.97%26.37M

Lease liabilities

-76.34%385.37K

-70.91%612.45K

-54.69%1.17M

-67.59%1.15M

49.68%1.63M

29.74%2.11M

19.77%2.58M

-37.27%3.54M

-52.16%1.09M

--1.62M

Total non current liabilities

-13.28%64.36M

-15.52%65.75M

-16.91%65.75M

24.45%69.22M

36.79%74.22M

40.27%77.83M

33.33%79.13M

-11.70%55.62M

-11.08%54.26M

-7.72%55.48M

Total liabilities

32.61%650.19M

24.35%685.98M

-16.84%669.05M

-28.13%457.59M

-15.19%490.3M

-3.92%551.63M

44.12%804.57M

18.17%636.71M

-18.21%578.13M

-39.60%574.11M

Shareholders equity

Paid-in capital

0.00%2.06B

Capital reserve funds

1.40%1.02B

1.67%1.01B

0.29%1.01B

0.47%1.01B

0.65%1.01B

3.71%988.87M

6.10%1B

6.89%1B

Surplus reserve funds

0.00%129.88M

6.50%129.88M

0.00%121.95M

Retained profit

-13.42%1.55B

-15.30%1.55B

-14.25%1.55B

-1.13%1.78B

-0.13%1.79B

2.31%1.83B

2.15%1.8B

-34.81%1.8B

-33.76%1.8B

-35.30%1.79B

Other composite income

-66.46%37.29M

69.61%42.14M

60.43%76.09M

25.43%100.92M

848.56%111.19M

123.22%24.85M

147.21%47.43M

212.39%80.46M

81.34%-14.85M

-132.57%-107.01M

Specific reserves

-18.22%659.97K

-42.40%510.78K

-53.22%426.84K

-48.40%675K

-37.93%807.01K

-34.59%886.83K

-29.97%912.5K

-22.23%1.31M

-24.50%1.3M

-25.20%1.36M

Shareholders equity without minority interests

-5.89%4.8B

-4.93%4.81B

-4.26%4.84B

0.47%5.08B

2.70%5.1B

3.80%5.05B

4.12%5.05B

-13.30%5.06B

-13.77%4.97B

-16.66%4.87B

Minority interests

-157.06%-25.96M

-422.71%-29.21M

-9,634.62%-26.03M

-530.76%-15.47M

-254.44%-10.1M

-129.62%-5.59M

-98.79%273.02K

-86.11%3.59M

-77.73%6.54M

-39.43%18.86M

Total shareholder equity

-6.22%4.78B

-5.40%4.78B

-4.78%4.81B

0.10%5.07B

2.36%5.09B

3.29%5.05B

3.64%5.05B

-13.62%5.06B

-14.10%4.98B

-16.78%4.89B

Total liabilityies and equity

-2.81%5.43B

-2.47%5.46B

-6.43%5.48B

-3.06%5.52B

0.53%5.58B

2.53%5.6B

7.80%5.86B

-10.94%5.7B

-14.54%5.56B

-19.96%5.46B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022
Assets
Current assets
Money funds	17.24%638.9M	-0.88%535.04M	-2.66%744.35M	39.04%501.64M	-32.27%544.93M	-0.02%539.8M	0.41%764.67M	-12.35%360.8M	35.97%804.62M	-47.89%539.93M
Transactional financial assets	927.01%100M	-85.36%143.2K	-99.90%118.6K	----	41.04%9.74M	--978.23K	--114.12M	1,282.17%17.97M	--6.9M	----
Notes receivable and accounts receivable	-8.35%132.01M	-13.39%143.89M	-7.74%146.99M	-42.65%119.31M	-26.64%144.03M	-10.09%166.14M	-15.81%159.33M	-56.52%208.04M	-46.70%196.34M	-54.64%184.79M
-Notes receivable	86.80%24.57M	11.71%35.1M	47.61%37.84M	-96.17%2.12M	-28.96%13.15M	--31.42M	831.26%25.63M	-63.58%55.48M	-82.78%18.52M	----
-Accounts receivable	-17.91%107.44M	-19.24%108.8M	-18.35%109.15M	-23.19%117.18M	-26.40%130.87M	-27.09%134.72M	-28.31%133.69M	-53.23%152.56M	-31.83%177.82M	-38.68%184.79M
Other receivables (including interest and dividends)	0.26%10.89M	135.81%19.26M	-34.66%18.17M	32.31%9.19M	10.93%10.86M	-16.58%8.17M	105.00%27.81M	69.24%6.95M	34.35%9.79M	64.65%9.79M
-Other receivable	0.26%10.89M	----	-34.66%18.17M	----	10.93%10.86M	----	105.00%27.81M	----	34.35%9.79M	----
Advance payment	-83.03%9.17M	-32.29%75.19M	-90.41%8.09M	102.69%151.05M	-37.17%54.02M	34.97%111.05M	-11.17%84.33M	-28.54%74.52M	7.39%85.97M	-41.61%82.28M
Inventories	-16.66%691.49M	-17.82%701.29M	-15.80%691.6M	-19.40%731.12M	0.32%829.67M	11.08%853.42M	14.91%821.34M	14.47%907.06M	-3.75%827M	-2.17%768.32M
Receivable financing	17.45%40.52M	144.02%34.21M	-31.77%30.81M	-55.72%31.66M	-15.87%34.5M	-86.08%14.02M	-46.95%45.15M	--71.5M	--41.01M	--100.74M
Other current assets	-47.02%69.29M	27.61%216.4M	22.07%90.88M	-68.02%150.98M	93.99%130.77M	-45.82%169.58M	-14.59%74.45M	-11.08%472.06M	-87.66%67.41M	-38.35%312.97M
Total current assets	-3.77%1.69B	-7.39%1.73B	-17.22%1.73B	-20.01%1.69B	-13.76%1.76B	-6.79%1.86B	7.44%2.09B	-8.79%2.12B	-16.88%2.04B	-30.68%2B
Non Current assets
Other equity investment	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	0.00%50M	--50M
Investment real estate	-3.87%79.69M	-4.65%80.49M	-4.66%81.29M	-4.67%82.09M	-4.68%82.89M	-3.86%84.42M	-3.83%85.26M	-3.79%86.11M	-3.75%86.96M	-3.72%87.81M
Long-term equity investment	-4.52%119.66M	-4.53%119.9M	-13.48%120.23M	-10.94%124.74M	-12.66%125.32M	-13.17%125.59M	-4.92%138.97M	-9.34%140.05M	-8.00%143.48M	-7.42%144.65M
Fixed assets	-2.78%2.55B	----	-3.87%2.58B	----	27.01%2.63B	----	35.19%2.68B	----	-19.69%2.07B	----
Constru in process	110.74%237.9M	----	276.78%199.38M	----	-76.04%112.89M	----	-89.32%52.92M	----	-5.90%471.16M	----
Construction materials	-86.37%8.01M	----	--21.51M	----	1,847.16%58.8M	----	----	----	52.15%3.02M	----
Intangible assets	-6.29%366.61M	-7.15%372.25M	-6.92%378.03M	-6.69%384.88M	-6.59%391.2M	-5.70%400.93M	-5.87%406.14M	-21.16%412.47M	-18.61%418.81M	-19.42%425.14M
Goodwill	-79.98%2M	-79.98%2M	-79.98%2M	0.00%10.01M	0.00%10.01M	0.00%10.01M	0.00%10.01M	-54.15%10.01M	-54.15%10.01M	-54.15%10.01M
Long deferred expense	-38.47%10.96M	-26.06%13.62M	-38.05%12.08M	-12.78%16.72M	-2.42%17.81M	20.70%18.42M	18.06%19.5M	15.85%19.17M	30.18%18.25M	21.02%15.26M
Deferred tax assets	-8.05%151.73M	-10.20%152.05M	-9.93%152.14M	50.98%161.87M	50.91%165.01M	45.82%169.33M	42.74%168.92M	92.79%107.22M	92.44%109.35M	121.80%116.12M
Usufruct assets	-4.65%117.03M	-1.24%117.66M	-2.72%118.61M	-3.78%120.71M	4.83%122.73M	5.90%119.13M	6.48%121.92M	1,562.71%125.45M	2,700.43%117.08M	--112.5M
Other non current assets	-37.83%40.06M	-51.83%31.04M	19.17%34.96M	79.18%46M	206.16%64.43M	291.80%64.45M	46.01%29.33M	-52.13%25.67M	-66.86%21.04M	-78.35%16.45M
Total non current assets	-2.36%3.74B	-0.02%3.74B	-0.44%3.75B	6.97%3.83B	8.82%3.83B	7.91%3.74B	8.01%3.76B	-12.17%3.58B	-13.13%3.52B	-12.12%3.46B
Total assets	-2.81%5.43B	-2.47%5.46B	-6.43%5.48B	-3.06%5.52B	0.53%5.58B	2.53%5.6B	7.80%5.86B	-10.94%5.7B	-14.54%5.56B	-19.96%5.46B
Liabilities
Current liabilities
Short term loan	128.33%340.21M	76.40%351.03M	-13.80%341.89M	-49.97%149M	-48.07%149M	-27.04%199M	61.24%396.64M	21.05%297.79M	-27.55%286.92M	-58.86%272.75M
Transactional financial liabilities	----	----	--538.4K	----	----	----	----	----	----	----
Notes payable and accounts payable	-11.60%146.14M	-7.25%157.4M	-38.45%122.3M	-10.66%139.03M	46.10%165.32M	38.37%169.7M	44.12%198.7M	33.60%155.61M	-18.08%113.16M	-6.41%122.64M
-Notes payable	----	----	----	----	----	----	----	--35M	----	----
-Accounts payable	-11.60%146.14M	-7.25%157.4M	-38.45%122.3M	15.27%139.03M	46.10%165.32M	38.37%169.7M	44.12%198.7M	3.55%120.61M	-18.08%113.16M	-6.41%122.64M
Contract liabilities	18.36%38.95M	6.39%36.72M	-8.36%47.01M	-9.18%36.93M	-18.38%32.91M	-32.44%34.51M	37.37%51.31M	-19.23%40.66M	-11.78%40.33M	19.55%51.08M
Salaries payable	-5.62%9.94M	-8.80%10.56M	11.45%23.86M	-25.50%10.34M	-22.54%10.53M	-16.39%11.58M	-30.06%21.41M	-2.66%13.88M	-7.02%13.59M	-1.36%13.85M
Taxs payable	-57.69%8.03M	-39.36%8.06M	151.93%9.3M	-29.23%14.45M	23.81%18.97M	104.70%13.3M	-23.14%3.69M	45.28%20.42M	21.37%15.32M	-11.72%6.5M
Other payable (including interest and dividends)	-18.61%26.79M	-21.94%29.5M	-26.53%31.85M	-28.98%31.9M	-29.25%32.92M	-11.99%37.79M	27.63%43.35M	59.79%44.92M	45.11%46.53M	59.09%42.93M
-Interest payable	----	----	----	----	----	----	----	--1.79M	--845.64K	----
-Other payable	-18.61%26.79M	----	-26.53%31.85M	----	-27.94%32.92M	----	27.63%43.35M	----	42.47%45.69M	----
Non current liabilities due within one year	-16.62%1.87M	-36.84%2.18M	-47.51%2.16M	-17.45%2.08M	-21.56%2.25M	21.66%3.45M	5.76%4.11M	32.35%2.52M	50.18%2.86M	--2.84M
Other current liabilities	232.46%13.9M	453.90%24.78M	291.69%24.39M	-12.22%4.64M	-18.97%4.18M	-25.84%4.47M	40.00%6.23M	12.65%5.28M	7.81%5.16M	14.06%6.03M
Total current liabilities	40.80%585.83M	30.90%620.23M	-16.84%603.3M	-33.16%388.38M	-20.57%416.08M	-8.64%473.8M	45.40%725.43M	22.12%581.09M	-18.89%523.87M	-41.76%518.62M
Current liabilities
Deferred tax liabilities	-11.50%46.57M	-14.17%46.49M	-13.50%46.2M	74.80%49.5M	88.76%52.62M	97.03%54.16M	82.36%53.41M	1.44%28.32M	0.77%27.88M	-0.34%27.49M
Long term deferred income	-12.82%17.41M	-13.50%18.65M	-20.57%18.39M	-21.85%18.57M	-21.05%19.97M	-18.25%21.56M	-17.06%23.15M	-19.27%23.76M	-18.61%25.29M	-18.97%26.37M
Lease liabilities	-76.34%385.37K	-70.91%612.45K	-54.69%1.17M	-67.59%1.15M	49.68%1.63M	29.74%2.11M	19.77%2.58M	-37.27%3.54M	-52.16%1.09M	--1.62M
Total non current liabilities	-13.28%64.36M	-15.52%65.75M	-16.91%65.75M	24.45%69.22M	36.79%74.22M	40.27%77.83M	33.33%79.13M	-11.70%55.62M	-11.08%54.26M	-7.72%55.48M
Total liabilities	32.61%650.19M	24.35%685.98M	-16.84%669.05M	-28.13%457.59M	-15.19%490.3M	-3.92%551.63M	44.12%804.57M	18.17%636.71M	-18.21%578.13M	-39.60%574.11M
Shareholders equity
Paid-in capital	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B	0.00%2.06B
Capital reserve funds	1.40%1.02B	1.40%1.02B	1.40%1.02B	1.67%1.01B	0.29%1.01B	0.47%1.01B	0.65%1.01B	3.71%988.87M	6.10%1B	6.89%1B
Surplus reserve funds	0.00%129.88M	0.00%129.88M	0.00%129.88M	6.50%129.88M	6.50%129.88M	6.50%129.88M	6.50%129.88M	0.00%121.95M	0.00%121.95M	0.00%121.95M
Retained profit	-13.42%1.55B	-15.30%1.55B	-14.25%1.55B	-1.13%1.78B	-0.13%1.79B	2.31%1.83B	2.15%1.8B	-34.81%1.8B	-33.76%1.8B	-35.30%1.79B
Other composite income	-66.46%37.29M	69.61%42.14M	60.43%76.09M	25.43%100.92M	848.56%111.19M	123.22%24.85M	147.21%47.43M	212.39%80.46M	81.34%-14.85M	-132.57%-107.01M
Specific reserves	-18.22%659.97K	-42.40%510.78K	-53.22%426.84K	-48.40%675K	-37.93%807.01K	-34.59%886.83K	-29.97%912.5K	-22.23%1.31M	-24.50%1.3M	-25.20%1.36M
Shareholders equity without minority interests	-5.89%4.8B	-4.93%4.81B	-4.26%4.84B	0.47%5.08B	2.70%5.1B	3.80%5.05B	4.12%5.05B	-13.30%5.06B	-13.77%4.97B	-16.66%4.87B
Minority interests	-157.06%-25.96M	-422.71%-29.21M	-9,634.62%-26.03M	-530.76%-15.47M	-254.44%-10.1M	-129.62%-5.59M	-98.79%273.02K	-86.11%3.59M	-77.73%6.54M	-39.43%18.86M
Total shareholder equity	-6.22%4.78B	-5.40%4.78B	-4.78%4.81B	0.10%5.07B	2.36%5.09B	3.29%5.05B	3.64%5.05B	-13.62%5.06B	-14.10%4.98B	-16.78%4.89B
Total liabilityies and equity	-2.81%5.43B	-2.47%5.46B	-6.43%5.48B	-3.06%5.52B	0.53%5.58B	2.53%5.6B	7.80%5.86B	-10.94%5.7B	-14.54%5.56B	-19.96%5.46B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--
Auditor	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

300267 Hunan Er-kang Pharmaceutical

Hunan Er-kang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target